Literature DB >> 3972983

Comparative evaluation of commercial rubella virus antibody kits.

R A Wittenburg, M A Roberts, L B Elliott, L M Little.   

Abstract

Comparative evaluation of six commercial rubella virus antibody kits is described. A set of serum samples skewed toward nonreactive and low-positive rubella antibody levels was used because the goal of an immunity screening test is the detection of susceptible individuals. The M. A. Bioproducts Rubastat and the Hynson, Westcott and Dunning Rubascan were superior in achieving high sensitivity, specificity, and reproducibility. They also were the easiest and fastest tests to perform, and they require equipment available in most laboratories.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3972983      PMCID： PMC271605          DOI： 10.1128/jcm.21.2.161-163.1985

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  3 in total

1.  Comparison of an enzyme-linked immunosorbent assay with indirect hemagglutination and hemagglutination inhibition for determination of rubella virus antibody: evaluation of immune status with commercial reagents in a clinical laboratory.

Authors:  A L Truant; B L Barksdale; T W Huber; L B Elliott
Journal:  J Clin Microbiol       Date:  1983-01       Impact factor: 5.948

2.  Evaluation of commercially available diagnostic test kits for rubella.

Authors:  G A Castellano; D L Madden; G T Hazzard; C S Cleghorn; D V Vails; A C Ley; N R Tzan; J L Sever
Journal:  J Infect Dis       Date:  1981-04       Impact factor: 5.226

3.  New latex agglutination test for rapid determination of rubella immune status.

Authors:  A S Weissfeld; A C Sonnenwirth
Journal:  J Clin Microbiol       Date:  1982-11       Impact factor: 5.948
  3 in total
  9 in total

1.  Evaluation of a new latex test and a new enzyme immunoassay for determination of rubella immunity.

Authors:  A E Simor; R Chua; D E Low
Journal:  J Clin Microbiol       Date:  1988-08       Impact factor: 5.948

2.  Differences in antibody responses with rapid agglutination tests for the detection of rubella antibodies.

Authors:  M A Chernesky; D J DeLong; J B Mahony; S Castriciano
Journal:  J Clin Microbiol       Date:  1986-04       Impact factor: 5.948

3.  Evaluation of a latex agglutination test for screening antibodies to rubella virus.

Authors:  P León; F de Ory; C Domingo; J A López; J M Echevarría
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-04       Impact factor: 3.267

4.  Monoclonal antibody-defined epitope map of expressed rubella virus protein domains.

Authors:  J S Wolinsky; M McCarthy; O Allen-Cannady; W T Moore; R Jin; S N Cao; A Lovett; D Simmons
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

5.  Determination of immune status in patients with low antibody titers for rubella virus.

Authors:  S L Fayram; S Akin; S L Aarnaes; E M Peterson; L M de la Maza
Journal:  J Clin Microbiol       Date:  1987-01       Impact factor: 5.948

6.  Comparison of a new, rapid enzyme immunoassay with a latex agglutination test for qualitative detection of rubella antibodies.

Authors:  M J Ferraro; W M Kallas; K P Welch; A Y Lau
Journal:  J Clin Microbiol       Date:  1987-09       Impact factor: 5.948

7.  An antibody- and synthetic peptide-defined rubella virus E1 glycoprotein neutralization domain.

Authors:  J S Wolinsky; E Sukholutsky; W T Moore; A Lovett; M McCarthy; B Adame
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

8.  Evaluation of microparticle enzyme immunoassays for immunoglobulins G and M to rubella virus and Toxoplasma gondii on the Abbott IMx automated analyzer.

Authors:  L E Schaefer; J W Dyke; F D Meglio; P R Murray; W Crafts; A C Niles
Journal:  J Clin Microbiol       Date:  1989-11       Impact factor: 5.948

9.  Evaluation of rubella immune status by three commercial enzyme-linked immunosorbent assays.

Authors:  P R Field; D W Ho; A L Cunningham
Journal:  J Clin Microbiol       Date:  1988-05       Impact factor: 5.948
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.